With a simple skin biopsy, researchers can learn about neurological conditions that may be associated with long COVID.

Jeffrey Rudolph ’78 developed a master plan to build the California Science Center into a center of science, learning, and ...

In a new review paper, researchers from the Universities of Arizona, Oxford and Leeds analyzed dozens of previous studies into long COVID to examine the number and range of people affected, the ...

Researchers have published more than 24,000 papers on long COVID — a constellation of health effects such as shortness of breath, fatigue, brain fog and heart failure that last months or years ...

A new study finds the risks of developing long COVID declined over the first two years of the pandemic. But unvaccinated adults were more than twice as likely to get long COVID compared with those ...

New studies have provided novel insights into long COVID, which continues to affect millions of people worldwide. The exact rates of the disease are hard to determine because of variations in clinical ...

One of the most reassuring aspects of the study was the absence of any significant rise in neurological complications linked ...

Researchers identified genetic loci and phenotypes linked to long-COVID in the largest multi-ethnic GWAS, revealing increased risk factors for chronic conditions like fatigue, depression, and ...

The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to market. Patients and scientists say it's time to push harder for breakthroughs.

Scientists have learned more about how SARS-CoV-2 infections, which cause COVID-19, can ruin the ability of immune cells to repair lung damage. This could help explain some of the symptoms experienced ...

Long COVID affects nearly every organ system. Scientists race to learn why it causes lasting damage.

Long COVID has challenged modern medicine in ways few conditions have. Its complex, multi-system nature has exposed gaps in healthcare and scientific knowledge.